Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4339 results

Sort By:

Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）

Study ID: NCT07069894
Start Date: 2025-08-01
End Date: 2027-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5400

Intervention / Treatment
Sponsor

Southeast University, China

Source: clinicaltrials.gov

Share:
Add to list

No More Sleepless Nights in Perimenopause

Study ID: NCT06497894
Start Date: 2025-08-01
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

54

Intervention / Treatment

Cognitive Behavioural Therapy for Insomnia (CBT-I)

Hormone Replacement Therapy (HRT)

Sleep Hygiene

Sponsor

Insel Group AG, University Hospital Bern

Source: clinicaltrials.gov

Share:
Add to list

A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients

Study ID: NCT07052994
Start Date: 2025-12-01
End Date: 2034-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Revenue

Cytrabine

Etrorior

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Study ID: NCT06762548
Start Date: 2025-10-10
End Date: 2026-11-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

And-007

Placebo

Sponsor

Applied Biology, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Study ID: NCT07078357
Start Date: 2025-10-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

StrepIncor

Placebo

Sponsor

University of Sao Paulo General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Study ID: NCT07062627
Start Date: 2025-09-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

Anbal-cel

Sponsor

Hyungwoo Cho

Source: clinicaltrials.gov

Share:
Add to list

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Study ID: NCT06792825
Start Date: 2025-10-01
End Date: 2031-07-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

65

Intervention / Treatment

Tafsitamb

Rituximab

Lenalidomide

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

Study ID: NCT06948825
Start Date: 2025-08
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Metformin Hcl 850Mg Tab

Lifestyle Intervention

Enhanced Lifestyle Intervention

Sponsor

George Washington University

Source: clinicaltrials.gov

Share:
Add to list

Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.

Study ID: NCT07040930
Start Date: 2025-07-31
End Date: 2026-09-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

GenSci120

Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer

Study ID: NCT04381130
Start Date: 2025-09-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

EF-009

Sponsor

Everfront Biotech Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list